Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals

ObjectivesThe incidence of non-tuberculous mycobacterial pulmonary disease (NTM-PD) has increased steadily globally, but the current culture-based diagnosis of NTM-PD is difficult and time-consuming, leading to a high possibility of misdiagnosis. Therefore, new methods should be introduced to improv...

Full description

Bibliographic Details
Main Authors: Jing Wang, Huan Xu, Xi Wang, Jian Lan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.1083497/full
_version_ 1828055975255343104
author Jing Wang
Huan Xu
Xi Wang
Jian Lan
author_facet Jing Wang
Huan Xu
Xi Wang
Jian Lan
author_sort Jing Wang
collection DOAJ
description ObjectivesThe incidence of non-tuberculous mycobacterial pulmonary disease (NTM-PD) has increased steadily globally, but the current culture-based diagnosis of NTM-PD is difficult and time-consuming, leading to a high possibility of misdiagnosis. Therefore, new methods should be introduced to improve the processes for clinical diagnosis of this disease.MethodsOur retrospective observational study enrolled 12 NTM-PD patients who were identified by way of metagenomic next-generation sequencing (mNGS), as well as the characteristic radiological presentation of slowly progressed, usually concomitant bronchiectasis, small cavitary opacity, and multiple nodules that respond poorly to empirical antibiotic therapy. These patients received the recommended drug regimen based on the identified non-tuberculous mycobacteria (NTM) species. Clinical data, including symptoms, laboratory tests, dynamic computed tomography imaging, treatment, and outcome, were recorded and analyzed.ResultsThe results of mNGS were all positive, with the standard specifically mapped read numbers (SDSMRN) of NTM ranging from 1 to 766; this was confirmed in six patients via quantitative polymerase chain reaction (qPCR) analysis. The duration fromsample collection tomNGS results was 1–4 days. Among our 12 patients (except for one lost to follow-up) the CT imaging for 11 patients showed significant absorption of lesions.ConclusionsOur results draw attention to NTM infection as a possible cause of community-acquired pneumonia, especially in patients with suggestive radiological presentation and poor responses to empirical antibiotic therapy. Our study also indicated that mNGS represented a potentially effective tool for the rapid identification of NTM in the respiratory sample. Improved clinician awareness combined with the utilization of mNGS could guide earlier diagnosis and targeted treatment, and finally improved the prognoses of patients with NTM-PD.
first_indexed 2024-04-10T20:48:08Z
format Article
id doaj.art-88896e0a6dfc41b7a8a4b78ed9de49bb
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-04-10T20:48:08Z
publishDate 2023-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-88896e0a6dfc41b7a8a4b78ed9de49bb2023-01-24T05:20:16ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882023-01-011210.3389/fcimb.2022.10834971083497Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitalsJing Wang0Huan Xu1Xi Wang2Jian Lan3Department of Respiratory and Critical Care Medicine, the Second Clinical Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Scientific Affairs, Vision Medicals Center for Infection Diseases, Guangzhou, ChinaDepartment of Respiratory and Critical Care Medicine, the Second Clinical Hospital of Chongqing Medical University, Chongqing, ChinaDepartment of Respiratory and Critical Care Medicine, the Second Clinical Hospital of Chongqing Medical University, Chongqing, ChinaObjectivesThe incidence of non-tuberculous mycobacterial pulmonary disease (NTM-PD) has increased steadily globally, but the current culture-based diagnosis of NTM-PD is difficult and time-consuming, leading to a high possibility of misdiagnosis. Therefore, new methods should be introduced to improve the processes for clinical diagnosis of this disease.MethodsOur retrospective observational study enrolled 12 NTM-PD patients who were identified by way of metagenomic next-generation sequencing (mNGS), as well as the characteristic radiological presentation of slowly progressed, usually concomitant bronchiectasis, small cavitary opacity, and multiple nodules that respond poorly to empirical antibiotic therapy. These patients received the recommended drug regimen based on the identified non-tuberculous mycobacteria (NTM) species. Clinical data, including symptoms, laboratory tests, dynamic computed tomography imaging, treatment, and outcome, were recorded and analyzed.ResultsThe results of mNGS were all positive, with the standard specifically mapped read numbers (SDSMRN) of NTM ranging from 1 to 766; this was confirmed in six patients via quantitative polymerase chain reaction (qPCR) analysis. The duration fromsample collection tomNGS results was 1–4 days. Among our 12 patients (except for one lost to follow-up) the CT imaging for 11 patients showed significant absorption of lesions.ConclusionsOur results draw attention to NTM infection as a possible cause of community-acquired pneumonia, especially in patients with suggestive radiological presentation and poor responses to empirical antibiotic therapy. Our study also indicated that mNGS represented a potentially effective tool for the rapid identification of NTM in the respiratory sample. Improved clinician awareness combined with the utilization of mNGS could guide earlier diagnosis and targeted treatment, and finally improved the prognoses of patients with NTM-PD.https://www.frontiersin.org/articles/10.3389/fcimb.2022.1083497/fullnon-tuberculous mycobacteria (NTM)pulmonary diseasemetagenomic next-generation sequencing (mNGS)rapid diagnosisearlier targeted treatment
spellingShingle Jing Wang
Huan Xu
Xi Wang
Jian Lan
Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals
Frontiers in Cellular and Infection Microbiology
non-tuberculous mycobacteria (NTM)
pulmonary disease
metagenomic next-generation sequencing (mNGS)
rapid diagnosis
earlier targeted treatment
title Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals
title_full Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals
title_fullStr Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals
title_full_unstemmed Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals
title_short Rapid diagnosis of non-tuberculous mycobacterial pulmonary diseases by metagenomic next-generation sequencing in non-referral hospitals
title_sort rapid diagnosis of non tuberculous mycobacterial pulmonary diseases by metagenomic next generation sequencing in non referral hospitals
topic non-tuberculous mycobacteria (NTM)
pulmonary disease
metagenomic next-generation sequencing (mNGS)
rapid diagnosis
earlier targeted treatment
url https://www.frontiersin.org/articles/10.3389/fcimb.2022.1083497/full
work_keys_str_mv AT jingwang rapiddiagnosisofnontuberculousmycobacterialpulmonarydiseasesbymetagenomicnextgenerationsequencinginnonreferralhospitals
AT huanxu rapiddiagnosisofnontuberculousmycobacterialpulmonarydiseasesbymetagenomicnextgenerationsequencinginnonreferralhospitals
AT xiwang rapiddiagnosisofnontuberculousmycobacterialpulmonarydiseasesbymetagenomicnextgenerationsequencinginnonreferralhospitals
AT jianlan rapiddiagnosisofnontuberculousmycobacterialpulmonarydiseasesbymetagenomicnextgenerationsequencinginnonreferralhospitals